Tilray shares are about to make a bounce back up. The shares have taken a 70% haircut in 2019, we think it's time to get back in to this stock.
"Tilray sold $15.8 million worth of recreational weed. International medical cannabis sales increased to $5.7 million from $949,000 a year ago. Tilray Chief Executive Brendan Kennedy said in an interview with MarketWatch that he attributes the international cannabis sales to investments the company made in 2017 and 2018 that are now beginning to bear fruit."
marketwatch.com/story/tilray-earnings-show-pot-sales-quintupling-beating-expectations-2019-11-12
finance.yahoo.com/news/tilray-options-traders-call-short-165728411.html
"Tilray sold $15.8 million worth of recreational weed. International medical cannabis sales increased to $5.7 million from $949,000 a year ago. Tilray Chief Executive Brendan Kennedy said in an interview with MarketWatch that he attributes the international cannabis sales to investments the company made in 2017 and 2018 that are now beginning to bear fruit."
marketwatch.com/story/tilray-earnings-show-pot-sales-quintupling-beating-expectations-2019-11-12
finance.yahoo.com/news/tilray-options-traders-call-short-165728411.html
免责声明
这些信息和出版物并非旨在提供，也不构成TradingView提供或认可的任何形式的财务、投资、交易或其他类型的建议或推荐。请阅读使用条款了解更多信息。
免责声明
这些信息和出版物并非旨在提供，也不构成TradingView提供或认可的任何形式的财务、投资、交易或其他类型的建议或推荐。请阅读使用条款了解更多信息。